Glenmark Pharma introduces generic eye treatment medication in US

Q: How long will it take to read this news story?

The story "Glenmark Pharma introduces generic eye treatment medication in US" has 142 words across 5 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Glenmark Pharma introduces generic eye treatment medication in US" was covered 7 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 230 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22137880</li><li>URL: https://beamstart.com/news/glenmark-pharma-introduces-generic-eye-17240676563</li></ul>

Business Standard Logo Business Standard 7h ago

Glenmark Pharma introduces generic eye treatment medication in US - Business Standard

Quick Summary:

Fabio Moreno, Head of OTC Sales & Marketing, Glenmark Pharmaceuticals Inc, said the launch of Olopatadine Ophthalmic Solution (USP, 0.1 per cent), addresses a growing demand for a new supplier in this category.

Glenmark Therapeutics Inc, USA has launched Olopatadine Hydrochloride Ophthalmic Solution (OTC) in the US market, the Mumbai-based drug maker said in a regulatory filing.

Glenmark Pharmaceuticals on Monday said its US-based subsidiary has introduced a generic medication used for eye itching.